⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

BEAM

Beam Therapeutics Inc.

Healthcare · Biotechnology

24.05USD

-0.5100 (-2.08%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on BEAM.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter-$1.17▲-$1.1745
Next quarter-$1.19▲-$1.236
Current year-$4.45▼-$4.4345
Next year-$4.77▼-$4.7353

Recent quarters

Beat in 2 of the last 4

QuarterEstimateActualSurprise
2026-06-30-$1.13-$1.18-0.05 (-4.8%)
2026-03-31-$1.01-$0.91+0.10 (+10.1%)
2025-12-31-$1.12$2.33+3.45 (+309.0%)
2025-09-30-$1.01-$1.1-0.09 (-9.0%)

Wall Street coverage

92 ratings from 24 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
HC Wainwright & Co.ReiteratedBuy$80Oct 15, 2026
WedbushReiteratedOutperform$65Oct 14, 2026
WedbushReiteratedOutperform$65Sep 9, 2026
HC Wainwright & Co.ReiteratedBuy$80Aug 25, 2026
B of A SecuritiesReiteratedBuy$47Jul 8, 2026
HC Wainwright & Co.ReiteratedBuy$80Jul 7, 2026
BernsteinMaintainedOutperform$40 $39May 13, 2026
CitigroupMaintainedBuy$64 $68Mar 26, 2026
RBC CapitalMaintainedSector Perform$22 $26Feb 25, 2026
WedbushMaintainedOutperform$57 $65Feb 25, 2026
Canaccord GenuityInitiatedBuy$74Feb 20, 2026
BernsteinMaintainedOutperform$37 $41Jan 21, 2026
UBSInitiatedNeutral$28Jan 7, 2026
Evercore ISI GroupInitiatedOutperform$35Nov 24, 2025
HC Wainwright & Co.ReiteratedBuy$80Oct 10, 2025
JP MorganMaintainedOverweight$48 $46Oct 9, 2025
HC Wainwright & Co.ReiteratedBuy$80Sep 15, 2025
BarclaysMaintainedEqual-Weight$25 $21Aug 6, 2025
GuggenheimMaintainedBuy$78 $55May 7, 2025
Wells FargoMaintainedOverweight$75 $70May 7, 2025
BarclaysMaintainedEqual-Weight$31 $25May 7, 2025
HC Wainwright & Co.ReiteratedBuy$80Apr 7, 2025
B of A SecuritiesUpgraded from NeutralBuy$42Mar 28, 2025
Cantor FitzgeraldReiteratedOverweight—Mar 12, 2025
ScotiabankUpgraded from Sector PerformSector Outperform$40Mar 10, 2025

Insider transactions

72 filings from 10 insiders · 2 buy / 4 sell over 6m

Officers and directors of BEAM, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
Evans John M.Director; Officer, CEOExerciseStock Option (Right to Buy)25.0k——Oct 16, 2026
Evans John M.Director; Officer, CEOSell25.0k$23.98$600kOct 16, 2026
Evans John M.Director; Officer, CEOExercise25.0k$1.03$26kOct 16, 2026
Evans John M.Director; Officer, CEOExerciseStock Option (Right to Buy)25.0k——Oct 15, 2026
Evans John M.Director; Officer, CEOSell25.0k$23.57$589kOct 15, 2026
Evans John M.Director; Officer, CEOExercise25.0k$1.03$26kOct 15, 2026
Cavanagh Bethany JOfficer, SVP, Finance and TreasurerSell187$24.41$5kOct 1, 2026
Ciaramella GiuseppeOfficer, PresidentGift123.4k——Sep 24, 2026
SIMON AMYOfficerSell16.7k$25.74$429kJul 27, 2026
EVANS JOHN M.Chief Executive OfficerExercise50.0k$0.67$45kJun 30, 2026
SIMON AMYOfficerSell373$34.73$13kJun 30, 2026
EVANS JOHN M.Chief Executive OfficerSell50.0k$34.26$1.75MJun 30, 2026
FMR, L.L.C.Beneficial Owner of more than 10% of a Class of SecuritySellindirect284.9k$35.12$10.04MJun 26, 2026
CIARAMELLA GIUSEPPEPresidentExercise35.5k$0.67$34kJun 17, 2026
CAVANAGH BETHANY JOfficer and TreasurerSell3.2k$24.58$80kApr 1, 2026
SIMON AMYOfficerSell6.7k$24.58$165kApr 1, 2026
BELLON CHRISTINEOfficerSell6.0k$24.58$146kApr 1, 2026
EVANS JOHN M.Chief Executive OfficerSell30.1k$24.58$739kApr 1, 2026
CIARAMELLA GIUSEPPEPresidentSell11.8k$24.58$290kApr 1, 2026
CAVANAGH BETHANY JOfficer and TreasurerGrant20.0k——Mar 31, 2026

Analyst Notes

Sign in to write

No analyst notes on BEAM yet.

Top voices on BEAM

Members whose judged calls on BEAM have played out most reliably.

No settled calls on BEAM yet. Nobody has filed a call with a deadline on it.

A member is listed once they have three judged calls on a name.

Sign in to make a call

A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.

A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.

A member’s prediction, judged on price history · not investment advice

Analyst Ratings

13 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current112200Buy2.07
1 mo ago112200Buy2.07
2 mo ago112200Buy2.07
3 mo ago112200Buy2.07
Price target$52.15$26.00 – $80.00
+116.9% to target